| Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018 | 1033 | 2018 |
| Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind … JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... The Lancet Neurology 16 (12), 976-986, 2017 | 635 | 2017 |
| Relationship between major depression and heart rate variability.: Clinical consequences and implications for antidepressive treatment MW Agelink, C Boz, H Ullrich, J Andrich Psychiatry research 113 (1-2), 139-149, 2002 | 561 | 2002 |
| Defining secondary progressive multiple sclerosis J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ... Brain 139 (9), 2395-2405, 2016 | 434 | 2016 |
| Geographical variations in sex ratio trends over time in multiple sclerosis M Trojano, G Lucchese, G Graziano, BV Taylor, S Simpson Jr, V Lepore, ... PloS one 7 (10), e48078, 2012 | 276 | 2012 |
| Defining reliable disability outcomes in multiple sclerosis T Kalincik, G Cutter, T Spelman, V Jokubaitis, E Havrdova, D Horakova, ... Brain 138 (11), 3287-3298, 2015 | 218 | 2015 |
| Predictors and dynamics of postpartum relapses in women with multiple sclerosis SE Hughes, T Spelman, OM Gray, C Boz, M Trojano, A Lugaresi, ... Multiple Sclerosis Journal 20 (6), 739-746, 2014 | 218 | 2014 |
| Predictors of long‐term disability accrual in relapse‐onset multiple sclerosis VG Jokubaitis, T Spelman, T Kalincik, J Lorscheider, E Havrdova, ... Annals of neurology 80 (1), 89-100, 2016 | 217 | 2016 |
| Sex as a determinant of relapse incidence and progressive course of multiple sclerosis T Kalincik, V Vivek, V Jokubaitis, J Lechner-Scott, M Trojano, G Izquierdo, ... Brain 136 (12), 3609-3617, 2013 | 210 | 2013 |
| Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS KA Ribbons, P McElduff, C Boz, M Trojano, G Izquierdo, P Duquette, ... PloS one 10 (6), e0122686, 2015 | 203 | 2015 |
| Individual risk factors for carpal tunnel syndrome: an evaluation of body mass index, wrist index and hand anthropometric measurements C Boz, M Ozmenoglu, V Altunayoglu, S Velioglu, Z Alioglu Clinical neurology and neurosurgery 106 (4), 294-299, 2004 | 202 | 2004 |
| Status epilepticus after stroke SK Velioglu, M Özmenoğlu, C Boz, Z Alioglu Stroke 32 (5), 1169-1172, 2001 | 196 | 2001 |
| Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis T Kalincik, D Horakova, T Spelman, V Jokubaitis, M Trojano, A Lugaresi, ... Annals of Neurology 77 (3), 425-435, 2015 | 191 | 2015 |
| Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study T Kalincik, JWL Brown, N Robertson, M Willis, N Scolding, CM Rice, ... The Lancet Neurology 16 (4), 271-281, 2017 | 178 | 2017 |
| Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study A Altintas, B Petek, N Isik, M Terzi, F Bolukbasi, M Tavsanli, S Saip, C Boz, ... Multiple Sclerosis Journal 18 (10), 1448-1453, 2012 | 162 | 2012 |
| Fingolimod after natalizumab and the risk of short-term relapse VG Jokubaitis, V Li, T Kalincik, G Izquierdo, S Hodgkinson, R Alroughani, ... Neurology 82 (14), 1204-1211, 2014 | 158 | 2014 |
| Towards personalized therapy for multiple sclerosis: prediction of individual treatment response T Kalincik, A Manouchehrinia, L Sobisek, V Jokubaitis, T Spelman, ... Brain 140 (9), 2426-2443, 2017 | 121 | 2017 |
| The impact of migraine on epilepsy: a prospective prognosis study SK Velioglu, C Boz, M Özmenoglu Cephalalgia 25 (7), 528-535, 2005 | 120 | 2005 |
| Risk of relapse phenotype recurrence in multiple sclerosis T Kalincik, K Buzzard, V Jokubaitis, M Trojano, P Duquette, G Izquierdo, ... Multiple Sclerosis Journal 20 (11), 1511-1522, 2014 | 110 | 2014 |
| Seasonal variation of relapse rate in multiple sclerosis is latitude dependent T Spelman, O Gray, M Trojano, T Petersen, G Izquierdo, A Lugaresi, ... Annals of neurology 76 (6), 880-890, 2014 | 108 | 2014 |
